Abstract
BackgroundIntroduction of tumor necrosis factor alpha (TNF) inhibitors has revolutionized therapy of rheumatoid arthritis (RA). Immunogenicity with consequent formation of antidrug antibodies (ADAb) is most responsible factor for secondary resistance....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have